Specializing in the development of automated clinical instrumentation for the testing of Bacterial Culture in Urine and Biological Liquids.
Incorporated in 1988 as a privately owned company, Alifax® specializes in the development, production and distribution of automated clinical diagnostic instrumentation for the determination of Bacterial Culture in Urine and Human Biological Liquids. Recognizing the need for innovation in the diagnostic Health Care System, Alifax is strongly focused on scientific research and technology development. Alifax has obtained worldwide patents in bacteriology and continue to collaborate with experts in the field of microbiology to publish more than 100 national and international scientific papers.
Meridian Bioscience Inc.
Meridian Bioscience is a fully integrated life science company that manufactures and markets a broad range of innovative diagnostic test kits. Their products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. Meridian diagnostic products require little or no special equipment.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. For example, The CDC’s new guidelines recommend that laboratories perform Shiga toxin testing on all stools submitted for enteric pathogen testing. Meridian has always been a leader in the field of E. coli testing. Meridian was the first to provide an EIA microwell to detect Shiga toxin produced by E. coli (Premier™ EHEC), and Meridian has raised the bar again with the introduction of the rapid ImmunoCard STAT!® EHEC.